BNP Paribas Financial Markets
JBIO

BNP Paribas Financial Markets’s Jade Biosciences JBIO Stock Holding History

BNP Paribas Financial Markets’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.43M Buy
199,429
+170,805
+597% +$3.56M ﹤0.01% 2185
2026
Q1 		$402K Buy
28,624
+18,755
+190% +$272K ﹤0.01% 3702
2025
Q4 		$152K Sell
9,869
-5,062
-34% -$59.4K ﹤0.01% 4183
2025
Q3 		$129K Buy
14,931
+11,709
+363% +$95.7K ﹤0.01% 4190
2025
Q2 		$32.2K Buy
3,222
+2,563
+389% +$87.2K ﹤0.01% 4410
2025
Q1 		$57.9K Sell
659
-904
-58% -$79.4K ﹤0.01% 4239
2024
Q4 		$145K Buy
+1,563
New +$135K ﹤0.01% 4029
2022
Q4 		– Sell
-113
Closed -$65.7K – 4094
2022
Q3 		$65.7K Buy
+113
New +$75.4K ﹤0.01% 3911

Other funds holding JBIO

JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BNP Paribas Financial Markets's JBIO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Jade Biosciences (JBIO) stake by 597% in Q2 2026, buying an estimated $3.56M and bringing the position to 199,429 shares worth $4.43M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

BNP Paribas Financial Markets first reported a position in JBIO in Q3 2022 and has held it in 8 quarters since. 141 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • BNP Paribas Financial Markets held 199,429 shares of Jade Biosciences worth $4.43M as of Q2 2026.
  • BNP Paribas Financial Markets bought 170,805 Jade Biosciences shares in Q2 2026, an estimated $3.56M.
  • Jade Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #2185 holding.
  • BNP Paribas Financial Markets first reported a position in Jade Biosciences in Q3 2022 and has held it in 8 quarters since.
  • 141 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.